Functional Ingredients Once Again Uses Aim & Act's Expertise

Functional Ingredients Magazine has once again utilized the expertise of Aim & Act in China to support that publication. This article, which deals with the melamine contamination issues, points out Andrew Buirge, Chief Scientific Officer of Aim & Act as one of the preeminent experts in Chinese manufacturing and regulatory issues.  Review the article in the link below for additional information.

http://www.functionalingredientsmag.com/fimag/articleDisplay.asp?strArticleId=1915&strSite=FFNSITE&Screen=CURRENTISSUE

Visit http://www.aim-act.com to request a quote or learn more about the company.

Aim & Act Published in Top Magazine

Aim & Act, Inc. has been published yet again by Functional Ingredients Magazine, this time with a full article written by Ken Fichtler, CEO of Aim & Act, Inc. The article, entitled The Science of Selling Science, is all about the integration of science with marketing. Increasingly, this is an area that many companies are struggling with as more and more consumers demand rigorous scientific testing. With the ever increasing complexity of the regulatory climate and scandals erupting constantly, a firm like Aim & Act is crucial to the success (if not outright survival) of companies in the natural products industry.  The publishing of this article is exciting for Aim &* Act as it speaks to our competency above and beyond that which is provided by a traditional marketing or scientific firm.

Read the article at the link below,

http://www.functionalingredientsmag.com/fimag/articleDisplay.asp?strArticleId=1866&strSite=FFNSITE&Screen=CURRENTISSUE

More information on Aim & Act is available at:

http://www.aim-act.com/

Functional Ingredients Publishes Expert Commentary by Aim & Act

Functional Ingredients magazine has published expert commentary by Aim & Act, Inc. The commentary was on the regulatory issues that Chinese manufacturing operations have experienced recently. When Coca Cola found that most of its Chinese suppliers were non-compliant in one way or another, Functional Ingredients approached Aim & Act for our take on the issue. The link to the article is below.

http://www.functionalingredientsmag.com/fimag/articleDisplay.asp?strArticleId=1804&strSite=FFNSITE&Screen=ARTICLEARCHIVE

You can read more about Aim & Act's regulatory compliance services online at

http://www.aim-act.com/scientific_compliance.html

Aim & Act Published in Functional Ingredients

Aim & Act, Inc. was published in Functional Ingredients Magazine recently in an article about China and the U.S. FDA establishing offices there. The link to the article "China Continues to Dominate U.S. Regulatory Agenda" is below.

http://www.functionalingredientsmag.com/fimag/articleDisplay.asp?strArticleId=1789&strSite=FFNSITE&Screen=ARTICLEARCHIVE

This article shows that Aim & Act has expertise in an area most companies are afraid to even consider. As the leader in scientific marketing and consulting, we realize that trade with China and the manufacturing of goods in that country is a reality. Aim & Act has pledged to help make the products manufactured in China safer for the end consumers.

Visit Aim & Act online at the link below to learn more about our scientific services:

http://www.aim-act.com/scientific_services.html

FDA Cracks Down on Alternative Cancer Companies

Recently the U.S. Food and Drug Administration (FDA) issued warning letters to natural products companies involved in the sale of alternative "cancer cures." These companies, either by choice or by lack of knowledge were making illegal disease claims on their websites. These warning letters should serve as a wake-up call to not only the companies that received them but to any other company not in full compliance with the Dietary Supplement Health Education Act (DSHEA).

The FDA in conjunction with the Federal Trade Commission (FTC) police this law which has been in effect since 1994. Thought the vast majority of natural products providers have come to understand DSHEA and are in full compliance, those which are not are running a great risk. The FDA has performed product seizures, has levied fines and stopped companies from selling non-compliant products.

Aim & Act, Inc. (www.aim-act.com) as an avid proponent of integrative cancer treatment and alternative medicines, is fully capable of working with companies to quickly and painlessly come into full regulatory compliance. Aim & Act has significant and longstanding competency in the practical application of the Dietary Supplement Health and Education Act (DSHEA). We have the ability to quickly and cheaply review marketing and sales materials for compliance with all applicable FDA and FTC regulations. We can either simply provide a write-up of suggested changes or completely rework your marketing and sales materials using our in-house experts. Additionally, if the utmost in legal protection is required, Aim & Act has a relationship with one of the best DSHEA law firms in the world. We can do an initial review and then provide the materials to that law firm to give a company an exceptionally high level of legal protection in the most cost-effective way.

Aim & Act is different from any other firm in the world because we combine marketing and scientific services for companies in the natural products industry. Our scientific services include clinical trial design and performance including all types of safety and efficacy trials. With a warning letter from non-compliance comes a substantial amount of bad publicity. One of the best ways to combat this and show customers a dedication to their health by performing primary scientific studies on your products. These scientific studies can yield a significant amount of sales points for your products and put your customers at ease.

Now is the time to act. After a warning letter has been posted, it is available for all the world to see, forever. This will lead to a poor reputation and much more in the way of legal liability. It is best to resolve any issues now quietly and privately with Aim & Act.

Call Aim & Act today at 406-585-5593 or visit us online at www.aim-act.com.

Additional resources

Be sure to check out the other Aim & Act informational websites:

www.aim-act.com - Official Homepage of Aim & Act, Inc.

http://best.scientificfirm.ever.com/ - The Ever Project Aim & Act, Inc. Page

http://www.facebook.com/pages/Aim-Act-Inc/15063674602 - Aim & Act, Inc. on Facebook

Call today for a free consultation!

New Company Seeks to Make Foreign Products Safer

A small firm is taking on the problem of contaminations in international manufacturing

BOZEMAN, MONT. – With contaminations of foreign made food and drug products coming to light constantly, consumers have become increasingly and rightfully fearful about the origin of their consumable goods. For example, the contaminations of the blood thinner heparin alone killed over 100 people. The heparin was contaminated in the production process because of lax enforcement of manufacturing rules and regulations. In response to this, recent draft legislation proposed by the U.S. Food and Drug Administration (FDA) seeks to increase the number of foreign facility inspections and establish permanent operations in China.

In response to this growing threat to the American people, Aim & Act, Incorporated, an upstart firm is seeking to work with Chinese manufacturers to provide safer products to the United States. Aim & Act provides scientific marketing and consulting services internationally to pharmaceutical, natural products and medical device companies. With significant competency in Quality Assurance, Good Manufacturing Practices, Good Laboratory Practices as well as Process Design and Validation, Aim & Act is one of the only companies willing or able to take on this problem.

By concentrating much of its effort on Chinese companies and production facilities, Aim & Act hopes to assist foreign companies in applying the same standards of excellence in manufacturing found in the United States. Aim & Act hopes to stop other unnecessary contaminations before they happen. In less than one week, most manufacturing processes can complete a quality assurance audit. This detailed examination of each step in a manufacturing process identifies any problem areas and reduces the possibility of contaminations to virtually none.

“Inconsistencies and contaminations in manufacturing are easily avoided with a relatively minor investment of time and money” said Andrew Buirge, President of Consulting for Aim & Act, “but these kinds of contaminations are continuing to happen far too frequently and innocent people are dying because of it.”

Through a unique business model, Aim & Act bridges the traditional gap between marketing and science for foreign and domestic companies, thereby facilitating greater product uptake and return on investment for client companies.

Visit Aim & Act online at: www.Aim-Act.com, or call 406-585-5593.

###

Introducing Aim & Act, Inc.

The Leader in Scientific Marketing & Consulting Services.

Aim & Act is bridging the gap between science and marketing in the medical device, pharmaceutical drug and complimentary alternative medicine markets to provide cost effective and integrative solutions.

We aim to build strong relationships, trustworthy communications and successful companies through professional, creative expertise and strategic ingenuity by providing exceedingly competent consulting and marketing services targeted toward modern consumers.

Services

Marketing: Graphic design, marketing strategy, packaging design, distribution, public relations, copy writing, logo design, web design, advertising and branding.

Science: OSHA audits, GMP consulting, GLP consulting, process validation, FDA agent service, chemical analysis, quality assurance, biomaterial developement, clinical trial developement and other primary research.

Please see http://www.aim-act.com/ for additional information and a complete service list with descriptions.